CKPT

Checkpoint Therapeutics Inc

 
Common Stock SEC Reporting - Current
OTCQX U.S.
Verified Company Profile 11/03/2016
Contact Info
  • 2 Gansevoort St
  • 9th Floor
  • New York, NY 10014

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-K
CIK 0001651407
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2014
Employees 6 a/o Sep 30, 2016
Company Officers/Contacts
James F. Oliviero CEO
Garrett Gray VP, Fin. & Acct., Principal Fin. Officer
Company Directors
Michael S. Weiss Executive Chairman
Scott Boilen Independent Director, Audit Committee Member, Compensation Committee Member
Neil Herskowitz Independent Director, Audit Committee Member, Compensation Committee Member
Lindsay Rosenwald
Barry Salzman Independent Director, Audit Committee Member, Compensation Committee Member
Service Providers
Accounting/Auditing Firm
BDO USA, LLP
135 West 50th Street
New York, NY, 10020
United States
 
Securities Counsel
Alston & Bird, LLP
90 Park Avenue
New York City, NY, 10016
United States
 
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Ladenburg Thalmann & Co. Inc. on 11/3/2016.
CKPT Security Details
Share Structure
Market Value1 $222,830,169 a/o Mar 23, 2017
Authorized Shares 35,000,000 a/o May 04, 2016
Outstanding Shares 17,476,876 a/o Mar 06, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 12,326,870 a/o May 04, 2016
Par Value Not Available
Transfer Agent(s)
VStock Transfer LLC
Shareholders
Shareholders of Record 422 a/o Mar 17, 2017
Short Selling Data
Short Interest 0 (-100%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security